A fast, specific, sensitive high-performance liquid chromatographic method for the determination of cefmetazole in human serum was developed. The serum samples were deproteinized by adding 5% trichloroacetic acid in methanol containing barbital as an internal standard and were injected onto a reverse-phase column (,u-Bondapak C18) with a mobile phase of 10 to 15% acetonitrile in 0.005 M citrate buffer (pH 5.4). Eluted components were detected by UV absorption at 254 nm. Cefmetazole and the internal standard were separated from interfering serum components by this method. The peak height ratio of cefmetazole to the internal standard was proportional to the cefmetazole concentration in the range from 0.4 to 100 ,ug/ml. Serum samples obtained from three patients after a single intravenous injection of cefmetazole were assayed by this method and by a microbiological method. There was a good correlation between the two assay methods (correlation coefficient, 0.98). The stability of cefmetazole in human serum was also determined by this method. Cefmetazole was stable in human serum for 2 weeks at 4°C or for at least 8 weeks if it was kept frozen. As the high-performance liquid chromatography method is simple, specific, accurate, and reproducible, it appears to be more suitable for routine assay of cephalosporins than other assay methods.
etamide-7-ot-methoxy-3-[[(1 -methyl-1H-tetrazolSyl)-thiolmethyl]-3-cephem-4-carboxylate), a new semisynthetic derivative of cephamycin developed by Sankyo Co., Ltd., Tokyo, Japan, has broad-spectrum antibacterial activity against gram-positive and gram-negative bacteria, in addition to high resistance to inactivation by several 3-lactamases. It also has high antibacterial activity against indole-positive Proteus and Serratia strains, against which commercial cephalosporin and penicillin antibiotics are ineffective. Cefmetazole has been used widely since it was introduced in 1980 and has proved to be an excellent antibiotic (3) (4) (5) 7) .
Although body fluid levels of cefmetazole have been determined by a microbiological assay (7), rapid monitoring of this drug in body fluids is often necessary in clinical situations. Therefore, we used high-performance liquid chromatography (HPLC) to determine cefmetazole levels in human serum. This technique requires extraction of the bound drug from human serum proteins, which was readily achieved with 5% trichloroacetic acid in methanol.
MATERIALS AND METHODS
Antibiotics. Cefmetazole was used for the preparation of standard solutions, and cefmetazole sodium was used for the study of stability in human serum. Specificity. Commonly used antibiotics, such as gentamicin (5 ,ug/ml), netilmicin (5 p.g/ml), and amikacin (5 ,ug/ml), were tested with the HPLC method for interference with cefmetazole and barbital. However, this method was specific for cefmetazole in that aminoglycosides did not interfere with the measurement of this drug.
Comparison of the HPLC assay with the microbiological assay. Serum samples from three patients given 2 g of cefmetazole intravenously were assayed by both the HPLC method and the microbiological method. Curves of serum level versus time obtained by the two methods are shown in Fig. 3 , and the correlation between the two methods is shown in Fig. 4 . Although in Figure 5 shows the effect of temperature on the stability of cefmetazole in human serum. More than 98% of the initial cefmetazole in a preparation remained unchanged when it was stored for 2 weeks at 5°C or for 8 weeks at -20°C. We observed no difference in stability between 100-and 10-,ug/ml cefmetazole preparations.
DISCUSSION
Cephalosporns are the most commonly used antibiotics in the treatment of infectious diseases. Large amounts of cephalosporins are often administered to save heavily infected patients. However, the risk of side effects and the potential toxicity due to overdose, especially in patients with hepatic dysfunction or renal dysfunction or both (2, 6, 8, 9) , could be prevented by rapid monitoring of serum drug levels.
Several analytical methods for the determination of cephalosporins in body fluids have been described previously. However, each method has its advantages and disadvantages. Microbiological assays (7) are time consuming, but they determine the antimicrobial serum activity. Fluorimetric assays (1, 10, 11) require cumbersome pretreatment of serum samples, although they are very sensitive methods. Therefore, we developed an HPLC method for determining cefmetazole in body fluids. Compared with the other methods available, the HPLC method is convenient for determining cephalosporins in body fluids for the following reasons: (i) it is rapid; (ii) it is a simple and reliable procedure; (iii) it has good reproducibility and sensitivity; and (iv) it is highly specific.
Under the experimental conditions which we used, the cefmetazole peak was well separated from the peaks of the other serum components (Fig. 1) . Moreover, high reproducibility was demonstrated by the variation coefficients (1.72 and 2.40%), and the assay had a sensitivity of 0.4 ,ug/ml. Therefore, determination of cefmetazole by this method was satisfactory within the therapeutic concentration range. Cefmetazole concentrations determined by the HPLC method were in good agreement with microbiological assay values.
